Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.

Acta pharmacologica Sinica 20140701

Activation of β-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells.

Toxicology 20140605

Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells.

The Journal of biological chemistry 20140418

Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death.

Cell death & disease 20140301

PI3K signaling mediates diverse regulation of ATF4 expression for the survival of HK-2 cells exposed to cadmium.

Archives of toxicology 20140201

3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.

Toxicology and applied pharmacology 20131101

The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells.

Toxicology letters 20130412

A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors.

PloS one 20130101

Discovery of novel potent and highly selective glycogen synthase kinase-3β (GSK3β) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines.

Journal of medicinal chemistry 20121108

IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.

Journal of cellular biochemistry 20121101

WNT/β-catenin-signaling pathway stimulates the proliferation of cultured adult human Sertoli cells via upregulation of C-myc expression.

Reproductive sciences (Thousand Oaks, Calif.) 20121101

Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains.

FEBS letters 20121019

Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling.

Toxicology and applied pharmacology 20121015

Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.

Molecular and cellular biochemistry 20121001

Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.

Biochemical and biophysical research communications 20120914

Roles of glycogen synthase kinase 3 in Alzheimer's disease.

Current Alzheimer research 20120901

Activation of Akt/protein kinase B mediates the protective effects of mechanical stretching against myocardial ischemia-reperfusion injury.

Journal of veterinary science 20120901

Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3β/β-catenin signaling pathway in ischemic rat myocardium.

Shock (Augusta, Ga.) 20120801

Wnt3a upregulates prostaglandin F2α-stimulated vascular endothelial growth factor synthesis in osteoblasts.

Molecular medicine reports 20120801

GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.

Molecular cancer research : MCR 20120801

Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP).

The Journal of biological chemistry 20120629

Acute inhibition of GSK causes mitochondrial remodeling.

American journal of physiology. Heart and circulatory physiology 20120601

Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.

Hepatobiliary & pancreatic diseases international : HBPD INT 20120601

Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120523

Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse.

Behavioural brain research 20120516

Apoptosis induced by SRC-family tyrosine kinase inhibitors in cultured rat cortical cells.

Neurotoxicity research 20120401

Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine.

Schizophrenia research 20120401

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.

Blood 20120308

Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.

Carcinogenesis 20120301

Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.

Oncogene 20120209

Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats.

FEBS letters 20120120

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

Toxicology and applied pharmacology 20120115

Muscle FBPase binds to cardiomyocyte mitochondria under glycogen synthase kinase-3 inhibition or elevation of cellular Ca2+ level.

FEBS letters 20120102

Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.

Biological & pharmaceutical bulletin 20120101

Wnt activation by wild type and mutant myocilin in cultured human trabecular meshwork cells.

PloS one 20120101

Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.

PloS one 20120101

Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.

The international journal of neuropsychopharmacology 20110901

Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.

The Biochemical journal 20110715

Glycogen synthase kinase 3β in the basolateral amygdala is critical for the reconsolidation of cocaine reward memory.

Journal of neurochemistry 20110701

Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.

Oncogene 20110526

GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.

American journal of physiology. Renal physiology 20110501

Tumor necrosis factor-α induces increased lung vascular permeability: a role for GSK3α/β.

European journal of pharmacology 20110425

The regulatory mechanism of melanogenesis by FTY720, a sphingolipid analogue.

Experimental dermatology 20110301

Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production.

Journal of neurochemistry 20110301

Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics.

Neuroscience 20110203

The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

Bioorganic & medicinal chemistry letters 20110101

RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity.

PloS one 20110101

Dendritic cell maturation occurs through the inhibition of GSK-3β.

Cellular immunology 20110101

AP-1 is a component of the transcriptional network regulated by GSK-3 in quiescent cells.

PloS one 20110101

Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling.

Cell & bioscience 20110101

Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta.

PloS one 20110101

Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome.

PloS one 20110101

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.

PloS one 20110101

Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

Neuropharmacology 20101101

Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.

Molecular cell 20101008

Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.

Bioorganic & medicinal chemistry 20100915

Colchicine-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells.

Cellular and molecular neurobiology 20100801

{beta}-Catenin regulates airway smooth muscle contraction.

American journal of physiology. Lung cellular and molecular physiology 20100801

Inhibition of glycogen synthase kinase 3beta prevents peroxide-induced collapse of mitochondrial membrane potential in rat ventricular myocytes.

Clinical and experimental pharmacology & physiology 20100701

Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100630

4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.

Journal of cellular and molecular medicine 20100601

Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.

Cardiovascular research 20100601

Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase.

American journal of physiology. Lung cellular and molecular physiology 20100601

Effects of areca nut extract on the apoptosis pathways in human neutrophils.

Journal of periodontal research 20100601

Neurites regrowth of cortical neurons by GSK3beta inhibition independently of Nogo receptor 1.

Journal of neurochemistry 20100601

Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice.

Brain research bulletin 20100531

GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20100421

Chelation of extracellular calcium-induced cell death was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells.

Cellular and molecular neurobiology 20100301

3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.

The Journal of pharmacology and experimental therapeutics 20100301

Benzo[e]isoindole-1,3-diones as potential inhibitors of glycogen synthase kinase-3 (GSK-3). Synthesis, kinase inhibitory activity, zebrafish phenotype, and modeling of binding mode.

Journal of medicinal chemistry 20100211

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

International journal of radiation oncology, biology, physics 20100201

Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70.

PloS one 20100101

Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

PloS one 20100101

Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice.

Vascular pharmacology 20100101

Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/beta-catenin pathway.

Cell proliferation 20091201

Regulation of serotonin 1B receptor by glycogen synthase kinase-3.

Molecular pharmacology 20091201

Glycogen synthase kinase 3beta in the nucleus accumbens core mediates cocaine-induced behavioral sensitization.

Journal of neurochemistry 20091201

Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway.

Molecular pharmacology 20091001

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Nature chemical biology 20091001

Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.

Neuropharmacology 20090901

The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.

Drug metabolism and disposition: the biological fate of chemicals 20090801

Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.

European journal of medicinal chemistry 20090601

Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells.

Biochimica et biophysica acta 20090601

The ceiling effect of pharmacological postconditioning with the phytoestrogen genistein is reversed by the GSK3beta inhibitor SB 216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through mitochondrial ATP-dependent potassium channel opening.

The Journal of pharmacology and experimental therapeutics 20090601

Cocaine-induced hyperactivity and sensitization are dependent on GSK3.

Neuropharmacology 20090601

Deregulation of Tpl2 and NF-kappaB signaling and induction of macrophage apoptosis by the anti-depressant drug lithium.

Cellular signalling 20090401

TNF-induced activation of pulmonary microvessel endothelial cells: a role for GSK3beta.

American journal of physiology. Lung cellular and molecular physiology 20090401

Cadmium toxicity toward autophagy through ROS-activated GSK-3beta in mesangial cells.

Toxicological sciences : an official journal of the Society of Toxicology 20090301

Knockin of mutant PIK3CA activates multiple oncogenic pathways.

Proceedings of the National Academy of Sciences of the United States of America 20090224

Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

Neuropharmacology 20090201

GSK3beta regulates differentiation and growth arrest in glioblastoma.

PloS one 20090101

Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.

Circulation research 20081024

Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells.

Archives of biochemistry and biophysics 20080901

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.

American journal of physiology. Cell physiology 20080901

Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition.

Anesthesia and analgesia 20080901

Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.

The Journal of pharmacology and experimental therapeutics 20080701

Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?

Neoplasia (New York, N.Y.) 20080601

Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.

European journal of pharmacology 20080531

Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.

Circulation 20080527

GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.

Journal of applied toxicology : JAT 20080501

Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.

American journal of hypertension 20080501

Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.

American journal of physiology. Heart and circulatory physiology 20080301

Inhibitors of GSK-3 prevent corticosterone from inducing COX-1 expression in cardiomyocytes.

Cardiovascular toxicology 20080101

The selectivity of protein kinase inhibitors: a further update.

The Biochemical journal 20071215

Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.

Journal of cellular biochemistry 20071201

MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta.

The Journal of biological chemistry 20071019

Media conditioned by retinal pigment epithelial cells suppress the canonical Wnt pathway.

Neuroscience letters 20070913

Cyclosporine A- and FK506-induced apoptosis in PC12 cells.

Cell biology and toxicology 20070901

Calmodulin inhibitor-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells.

Cellular and molecular neurobiology 20070901

GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.

Basic research in cardiology 20070701

Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway.

Cancer letters 20070628

Structure based de novo design of novel glycogen synthase kinase 3 inhibitors.

Bioorganic & medicinal chemistry 20070601

Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis.

Biochemical and biophysical research communications 20070309

Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates.

Molecular cancer therapeutics 20070301

An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.

Cancer research 20070101

Inhibiting glycogen synthase kinase 3beta in sepsis.

Novartis Foundation symposium 20070101

Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.

Journal of vascular research 20070101

Thapsigargin-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells.

Neuroscience letters 20061113

Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.

The Journal of pharmacology and experimental therapeutics 20061101

The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels.

Experimental cell research 20061101

[Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].

Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061101

Modulation of key elements of the Wnt pathway by apple polyphenols.

Journal of agricultural and food chemistry 20060920

Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells.

Journal of agricultural and food chemistry 20060920

Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.

Brain research 20060919

A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells.

Assay and drug development technologies 20060801

Prevention of rat cortical neurons from prostaglandin E2-induced apoptosis by glycogen synthase kinase-3 inhibitors.

Neuroscience letters 20060529

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.

Shock (Augusta, Ga.) 20060501

Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.

The Journal of biological chemistry 20060224

Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.

Oncogene 20060105

Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.

Journal of molecular and cellular cardiology 20060101

The Wnt signaling pathway as a target for the treatment of neurodegenerative disorders.

IDrugs : the investigational drugs journal 20060101

Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.

Cancer research 20051001

Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18.

Developmental biology 20050915

GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.

Critical care medicine 20050901

Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas.

Molecular cancer therapeutics 20050901

Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.

Cancer research 20050715

Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.

Clinical cancer research : an official journal of the American Association for Cancer Research 20050615

Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.

Cancer research 20050301

Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium.

Neuroscience 20050101

Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c.

The Journal of biological chemistry 20041210

Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.

Oncogene 20041014

Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons.

European journal of pharmacology 20040924

Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.

European journal of pharmacology 20040714

Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.

Circulation research 20040416

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

Oncogene 20040401

Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin.

Biochemical and biophysical research communications 20040319

Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.

Bioorganic & medicinal chemistry letters 20030915

Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity.

Neuroreport 20030806

Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.

The Biochemical journal 20021015

Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

The Journal of biological chemistry 20020419

Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective.

Circulation research 20020308

GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.

FEBS letters 20011102

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

Journal of neurochemistry 20010401

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Chemistry & biology 20001001

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

Diabetes 20000201

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.

Diabetes 19990801

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

Proceedings of the National Academy of Sciences of the United States of America 19930815

Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.

Molecular endocrinology (Baltimore, Md.)